BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19137706)

  • 21. Gene expression signatures defining fundamental biological processes in pluripotent, early, and late differentiated embryonic stem cells.
    Gaspar JA; Doss MX; Winkler J; Wagh V; Hescheler J; Kolde R; Vilo J; Schulz H; Sachinidis A
    Stem Cells Dev; 2012 Sep; 21(13):2471-84. PubMed ID: 22420508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion.
    Lahlil R; Scrofani M; Barbet R; Tancredi C; Aries A; Hénon P
    Stem Cell Rev Rep; 2018 Aug; 14(4):510-524. PubMed ID: 29736843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A regulatory circuitry locking pluripotent stemness to embryonic stem cell: Interaction between threonine catabolism and histone methylation.
    Chen G; Wang J
    Semin Cancer Biol; 2019 Aug; 57():72-78. PubMed ID: 30710616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PSCDGs of mouse multipotent adult germline stem cells can enter and progress through meiosis to form haploid male germ cells in vitro.
    Nolte J; Michelmann HW; Wolf M; Wulf G; Nayernia K; Meinhardt A; Zechner U; Engel W
    Differentiation; 2010; 80(4-5):184-94. PubMed ID: 20810205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human embryonic stem cells: mechanisms to escape replicative senescence?
    Zeng X
    Stem Cell Rev; 2007 Dec; 3(4):270-9. PubMed ID: 18026912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic remodeling during the loss and acquisition of pluripotency.
    Mathieu J; Ruohola-Baker H
    Development; 2017 Feb; 144(4):541-551. PubMed ID: 28196802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can pluripotent stem cells be used in cell-based therapy?
    Picanço-Castro V; Moreira LF; Kashima S; Covas DT
    Cell Reprogram; 2014 Apr; 16(2):98-107. PubMed ID: 24606201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryonic stem cell-related miRNAs are involved in differentiation of pluripotent cells originating from the germ line.
    Zovoilis A; Pantazi A; Smorag L; Opitz L; Riester GS; Wolf M; Zechner U; Holubowska A; Stewart CL; Engel W
    Mol Hum Reprod; 2010 Nov; 16(11):793-803. PubMed ID: 20566704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences between human embryonic stem cell lines.
    Allegrucci C; Young LE
    Hum Reprod Update; 2007; 13(2):103-20. PubMed ID: 16936306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncovering the true identity of naïve pluripotent stem cells.
    Welling M; Geijsen N
    Trends Cell Biol; 2013 Sep; 23(9):442-8. PubMed ID: 23685019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy to Establish Embryo-Derived Pluripotent Stem Cells in Cattle.
    Kim D; Roh S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between Metabolites and the Epigenome in Regulating Embryonic and Adult Stem Cell Potency and Maintenance.
    Harvey A; Caretti G; Moresi V; Renzini A; Adamo S
    Stem Cell Reports; 2019 Oct; 13(4):573-589. PubMed ID: 31597110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanog safeguards pluripotency and mediates germline development.
    Chambers I; Silva J; Colby D; Nichols J; Nijmeijer B; Robertson M; Vrana J; Jones K; Grotewold L; Smith A
    Nature; 2007 Dec; 450(7173):1230-4. PubMed ID: 18097409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
    Lee H; Park J; Forget BG; Gaines P
    Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines.
    Drukker M
    Semin Immunol; 2008 Apr; 20(2):123-9. PubMed ID: 18160306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional Control of Somatic Cell Reprogramming.
    Xu Y; Zhang M; Li W; Zhu X; Bao X; Qin B; Hutchins AP; Esteban MA
    Trends Cell Biol; 2016 Apr; 26(4):272-288. PubMed ID: 26776886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription regulation and chromatin structure in the pluripotent ground state.
    Marks H; Stunnenberg HG
    Biochim Biophys Acta; 2014 Mar; 1839(3):129-37. PubMed ID: 24096207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of Mouse Parthenogenetic Epiblast Stem Cells and Their Imprinting Patterns.
    Seo BJ; Jang HS; Song H; Park C; Hong K; Lee JW; Do JT
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New cell lines from mouse epiblast share defining features with human embryonic stem cells.
    Tesar PJ; Chenoweth JG; Brook FA; Davies TJ; Evans EP; Mack DL; Gardner RL; McKay RD
    Nature; 2007 Jul; 448(7150):196-9. PubMed ID: 17597760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions.
    Garitaonandia I; Amir H; Boscolo FS; Wambua GK; Schultheisz HL; Sabatini K; Morey R; Waltz S; Wang YC; Tran H; Leonardo TR; Nazor K; Slavin I; Lynch C; Li Y; Coleman R; Gallego Romero I; Altun G; Reynolds D; Dalton S; Parast M; Loring JF; Laurent LC
    PLoS One; 2015; 10(2):e0118307. PubMed ID: 25714340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.